Molecular Imaging: Page 416

Illinois MRI leasing case settled; contract renewal tips; medical isotope report

By Brian Casey

January 14, 2009

Report: Use of low-enriched uranium in medical isotopes is feasible

By Wayne Forrest

A new study from the National Academy of Sciences concluded that no technical barriers exist for converting medical isotope-producing nuclear reactors from high-enriched uranium to low-enriched uranium (LEU) for the production of molybdenum-99 (Mo-99). Chronic shortages might still persist in Mo-99 supply, however, even if such a conversion occurs.

January 14, 2009

UCLA study finds PET with FDDNP radiotracer can predict Alzheimer's

By Wayne Forrest

Researchers at the University of California, Los Angeles (UCLA) have produced additional evidence demonstrating that a new PET radiotracer is effective in diagnosing brain aging before symptoms appear, and in differentiating Alzheimer's disease from other less serious neurological conditions.

January 12, 2009

Bayer partners with Hamamatsu

By AuntMinnie.com staff writers

Bayer Schering Pharma and Hamamatsu Photonics have signed a licensing agreement to share their products and expertise in molecular imaging for cancer.

January 11, 2009

Positron launches cardiac nuclear medicine package

By AuntMinnie.com staff writers

PET developer Positron has debuted a comprehensive cardiac nuclear medicine program.

January 8, 2009

MRI beats PET for myocardial evaluation in patients with impaired LV function

By Eric Barnes

While MRI is known to detect more myocardial scarring than PET in patients with occlusive coronary artery disease, a new study suggests that contrast-enhanced MRI can make a critical difference in treatment planning for revascularization candidates with severely impaired left ventricular (LV) function.

January 8, 2009